Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

By Oefelein M.G.   Ricchiuti V.S.   Conrad P.W.   Goldman H.   Bodner D.   Resnick M.I.   Seftel A.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 120-124

Elsevier

Access to resources Recommend Favorite

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

By Ghossein R.A.   Rosai J.   Scher H.I.   Seiden M.   Zhang Z.-F.   Sun M.   Chang G.   Berlane K.   Krithivas K.   Kantoff P.W.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen and the biologic progression of prostate cancer

By Kabalin J.N.   McNeal J.E.   Johnstone I.M.   Stamey T.A.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 65-70

Elsevier

Access to resources Recommend Favorite

Androgen independent progression in prostate cancer: Risk factors

By Auzanneau C.   Irani J.   Dahmani L.   Ouaki F.   Pires C.   Dore B.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite